OPHTHALMOLOGY specialists at the General Hospital of Elche have patented a new drug they say can help combat blindness resulting from diabetes.
Diabetic retinopathy is a common complication of diabetes. It occurs when high blood sugar levels damage the cells at the back of the eye and, if not treated, can cause blindness. It is a leading cause of blindness in developed countries.
The new drug is the result of an original and unique research project, born in Elche’s General Hospital with the involvement of the Foundation for the Promotion of Health Research and Biomedical Valencia (FISABIO) and the University of Castilla-La Mancha.
Elche’s leading ophthalmologist, Dr Fernandez, said: “An industrial patent culminated from a study that has been conducted in animals and which has shown positive results in the treatment of this serious eye disease.”
According to the research, the new drug would be administered directly to patients and would offer better results with fewer side effects compared to existing drugs.
Pharmaceutical companies have already shown an interest in launching clinical trials.